Cargando…

Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression

OBJECTIVE: This study aims to assess the association of subject characteristics and NRAS mutations with HER2 expression in CRC. METHODS: This research is a cross-sectional study. The research subjects in this study were colorectal cancer patients in the Digestive Surgery division at Dr. Hasan Sadiki...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukman, Kiki, Reza, Ade Tan, Hasibuan, Lisa Y., Sribudiani, Yunia, Dewayani, Birgitta Maria, Rudiman, Reno, Primastari, Etis, Nugraha, Prapanca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352740/
https://www.ncbi.nlm.nih.gov/pubmed/37116161
http://dx.doi.org/10.31557/APJCP.2023.24.4.1373
_version_ 1785074574219542528
author Lukman, Kiki
Reza, Ade Tan
Hasibuan, Lisa Y.
Sribudiani, Yunia
Dewayani, Birgitta Maria
Rudiman, Reno
Primastari, Etis
Nugraha, Prapanca
author_facet Lukman, Kiki
Reza, Ade Tan
Hasibuan, Lisa Y.
Sribudiani, Yunia
Dewayani, Birgitta Maria
Rudiman, Reno
Primastari, Etis
Nugraha, Prapanca
author_sort Lukman, Kiki
collection PubMed
description OBJECTIVE: This study aims to assess the association of subject characteristics and NRAS mutations with HER2 expression in CRC. METHODS: This research is a cross-sectional study. The research subjects in this study were colorectal cancer patients in the Digestive Surgery division at Dr. Hasan Sadikin Hospital. There were 58 study subjects. Examination of NRAS mutations was carried out by Polymerase Chain Reaction (PCR) from fresh tumour tissue obtained from surgery or colonoscopy. Meanwhile, HER2 examination used the Immunohistochemistry (IHC) method of paraffin blocks for anatomical pathology examination of the same patients. RESULT: HER2 overexpression was found in 6/58 (10.3%) patients with CRC, and from 8 subjects with NRAS mutations, only 1 subject (1.7%) showed overexpression of HER2. Univariate analysis of HER2 expression showed no significant associations to age, sex, histologic feature, tumor location, and NRAS mutations. A significant association was found between HER2 expression and stage of the CRC with p=0.001. CONCLUSION: There is no association between NRAS mutations and HER2 overexpression in colorectal cancer patients.
format Online
Article
Text
id pubmed-10352740
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-103527402023-07-19 Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression Lukman, Kiki Reza, Ade Tan Hasibuan, Lisa Y. Sribudiani, Yunia Dewayani, Birgitta Maria Rudiman, Reno Primastari, Etis Nugraha, Prapanca Asian Pac J Cancer Prev Research Article OBJECTIVE: This study aims to assess the association of subject characteristics and NRAS mutations with HER2 expression in CRC. METHODS: This research is a cross-sectional study. The research subjects in this study were colorectal cancer patients in the Digestive Surgery division at Dr. Hasan Sadikin Hospital. There were 58 study subjects. Examination of NRAS mutations was carried out by Polymerase Chain Reaction (PCR) from fresh tumour tissue obtained from surgery or colonoscopy. Meanwhile, HER2 examination used the Immunohistochemistry (IHC) method of paraffin blocks for anatomical pathology examination of the same patients. RESULT: HER2 overexpression was found in 6/58 (10.3%) patients with CRC, and from 8 subjects with NRAS mutations, only 1 subject (1.7%) showed overexpression of HER2. Univariate analysis of HER2 expression showed no significant associations to age, sex, histologic feature, tumor location, and NRAS mutations. A significant association was found between HER2 expression and stage of the CRC with p=0.001. CONCLUSION: There is no association between NRAS mutations and HER2 overexpression in colorectal cancer patients. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10352740/ /pubmed/37116161 http://dx.doi.org/10.31557/APJCP.2023.24.4.1373 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Lukman, Kiki
Reza, Ade Tan
Hasibuan, Lisa Y.
Sribudiani, Yunia
Dewayani, Birgitta Maria
Rudiman, Reno
Primastari, Etis
Nugraha, Prapanca
Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title_full Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title_fullStr Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title_full_unstemmed Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title_short Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression
title_sort different clinicopathological characteristics in indonesian colorectal patients with nras mutations and her2 over-expression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352740/
https://www.ncbi.nlm.nih.gov/pubmed/37116161
http://dx.doi.org/10.31557/APJCP.2023.24.4.1373
work_keys_str_mv AT lukmankiki differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT rezaadetan differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT hasibuanlisay differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT sribudianiyunia differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT dewayanibirgittamaria differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT rudimanreno differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT primastarietis differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression
AT nugrahaprapanca differentclinicopathologicalcharacteristicsinindonesiancolorectalpatientswithnrasmutationsandher2overexpression